Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Explore zero based budgeting tips tailored for large families, focusing on scalable expense categorization and practical saving methods.
23,089 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
When two people share a life, their retirement plan should share the payoff. This guide breaks down why couples often...
BluePeak Capital disclosed it sold additional common shares to fund a $40 million bitcoin purchase, even as its total...
Tech-heavy stocks drive gains in a broad market rally on February 25, 2026, as investors react to policy cues and res...
A new ElevenLabs case study shows better.com’s Betsy AI voice agent slashing origination costs by 41% in 2025 while l...
Are the best-known stocks truly a massive opportunity or a trap built by hype? This guide breaks down 10 popular name...
Kontoor Brands posted Q4 2025 results with revenue above $1B and a solid earnings beat, driven by a key acquisition. ...
A former Seoul officer who oversaw crypto crime investigations received a six-year prison term for taking bribes. Thi...
A sharp February pullback put Intel back in focus. This guide breaks down the drivers, the long-term thesis, and how ...
Microsoft is doubling down on AI. This article lays out scenarios, risks, and concrete steps to understand where will...
NVIDIA’s AI surge is redefining the memory supply chain, and Micron investors face new headwinds. This deep dive expl...
Translucent closed a $27 million Series A to expand its AI-native healthcare finance platform, targeting improved rev...